急性期リハビリテーション市場：フェーズタイプ、デバイス製品タイプ、疾患タイプ、エンドユーザータイプ別- 世界予測2024-2030年

急性期リハビリテーション市場規模は2023年に546億7,000万米ドルと推計され、2024年には591億7,000万米ドルに達し、CAGR 8.45％で2030年には964億8,000万米ドルに達すると予測されます。

急性期リハビリテーションは、集中的な理学療法、作業療法、言語聴覚療法を必要とする重傷、手術、急性疾患を経験した患者のためにデザインされた専門医療です。急性期リハビリテーションは、患者が重要な健康上の出来事の後、機能的能力と自立性を可能な限り高いレベルまで回復させることを目的としています。高齢化と慢性疾患の増加が急性期リハビリテーションサービスの必要性を高めています。さらに、政府、保険政策、リハビリテーションサービスへの資金援助は、急性期リハビリテーションサービスの普及と利用に大きく影響します。しかし、専門的な治療には高額な費用がかかり、リハビリテーション分野では訓練を受けた専門家が不足しているため、急性期リハビリテーションソリューションの採用は世界的に限られています。とはいえ、ロボット支援リハビリやバーチャルリアリティのような革新的な治療法は、治療結果と効率を高めることができます。遠隔医療の進歩により、遠隔リハビリテーションサービスを取り入れることで、特に遠隔地の患者により多くの機会を提供することができます。さらに、人工知能を治療計画に組み込むことで、パーソナライズされたケアプランを最適化することができ、今後数年間で急性期リハビリテーションに関連する患者の転帰を改善できる可能性があります。

フェーズタイプ急性期治療に対する急性期リハビリテーションのニーズの高まり

i期では、重度の怪我や病気の発症後、患者は綿密な医学的管理とサポートを必要とします。リハビリテーションは非常に早期に、多くの場合病院内で開始され、主な目標は患者の病状を安定させ、長期のベッド上安静による問題を避けるために早期の動員を開始することです。i期で最も恩恵を受けるのは、医学的に不安定で、早急に集中的な医療とリハビリテーションサービスを必要とする患者です。患者が医学的に安定し、より長時間のリハビリテーションに耐えられるようになると、第II相に移行します。第II相は、急性期から進行したもの、外来では提供できない実質的な看護とリハビリテーションのサポートが必要な患者に最適です。第III相では、集中的な外来治療によってリハビリを継続します。第III相の理想的な患者さんは、最小限の介助で基本的な日常生活を送れる程度に回復しているが、集中的なリハビリテーションがまだ有効な患者さんです。第IV相はリハビリテーション・プロセスの最終段階であり、患者は自立した継続的なコンディショニング・プログラムを開始します。この段階は、自立度がかなり回復し、ヘルスケア専門家の時々の監督を受けながらコンディショニング・プログラムを管理できる患者を対象としています。

デバイス製品：急性期リハビリテーションセンターにおけるローワーの使用増加

血圧計は、患者の血圧値をモニターするために不可欠な機器であり、心臓の状態を管理し、全体的な健康状態を評価する上で極めて重要です。血圧計は、その精度とデータ記録機能によって好まれています。心拍数モニターは心臓のリズムと速度を追跡し、リハビリセッションを最適化し、心臓の健康状態をモニターするためのデータを提供します。ローワーは、低負荷で全身運動ができ、心血管系のフィットネスと筋力を向上させるため、急性期リハビリに好まれます。漕ぎ手の選択は、耐久性、抵抗レベル、人間工学的デザインによって決まる。座位型および直立型のエリプティカル・トレーナーは、関節にやさしいカーディオ・ワークアウトを提供し、その用途は多岐にわたります。スタビライゼーション・ボールは、バランス、コーディネーション、体幹の強さを向上させるために選ばれます。好みは、素材の質、サイズの多様性、ボールの耐荷重に関係することが多いです。固定式自転車は、関節に大きな衝撃を与えることなく、有酸素運動によるコンディショニングと下半身の強化に効果的であるため、リハビリ用に選択されます。トレッドミルは急性期リハビリテーションの有酸素運動と持久力運動の定番であり続けています。一般的には、様々な回復段階に対応できるよう、傾斜や速度、クッション性が変化するトレッドミルが求められています。

疾患タイプ：急性期リハビリテーションに対する消費者の嗜好は、高血圧の問題を克服すること。

不整脈は、心臓が不規則に鼓動する状態です。このような患者に対するリハビリテーションには、服薬の順守、生活習慣の調整、場合によってはペースメーカーや除細動器の導入などが含まれます。狭心症は心臓への血流が減少することによって引き起こされ、冠動脈疾患を示すことがあります。リハビリは多くの場合、症状の管理と心臓血管の健康状態を改善するために、運動プログラム、ストレス軽減、食生活の改善を伴う。心房細動（AFib）は、特に高齢者によくみられる重症の心拍異常の一種です。脳卒中を予防するための抗凝固薬は、心拍数とリズムをコントロールするための介入と並んで、主要な治療法です。心血管疾患患者のリハビリテーションでは、さらなる合併症を防ぐために効果的なコレステロール管理が重要です。冠動脈バイパス手術は重度の冠動脈疾患に対する重要な外科的介入です。術後のリハビリテーションには理学療法と生活習慣の改善が含まれます。冠動脈疾患や末梢動脈疾患（PAD）の治療には、生活習慣の改善、薬物療法、そして外科的介入の可能性があります。糖尿病管理には血糖モニタリング、インスリン療法、食事調節、教育が含まれます。主要メーカーは持続血糖モニターやインスリンポンプを提供しており、患者管理を支援しています。心不全や心臓移植後の患者には、症状を管理し、機能的能力を向上させ、再入院率を低下させるための専門的なリハビリテーションが必要です。高血圧の適切な管理は、脳卒中や心臓病などの合併症を予防するために不可欠です。肺高血圧症は、血圧を下げる薬物療法や外科的処置を含む複雑な管理が必要です。

エンドユーザーのタイプリハビリセンターにおける高度な急性期リハビリテーションソリューションの利用可能性

急性期リハビリテーションにおける在宅ケアとは、患者の住居で実施されるように設計されたサービスや介入を指します。在宅ケアは、病院での治療から移行する患者や、継続的なリハビリテーションを必要とするが医学的な複雑さの程度が低い患者を対象としています。病院や診療所は、入院および外来リハビリテーションサービスを提供する上で極めて重要です。これらの施設では、軽度から重度まで幅広いリハビリテーションのニーズに対応しています。これらの施設は一般的に、集中的なケアを提供するために、多職種のチームを備えた構造化された急性期リハビリテーションプログラムを持っています。リハビリテーションセンターは、著しい機能障害を持つ患者の回復に特化した専門施設です。これらのセンターでは、理学療法、作業療法、言語療法など、広範囲にわたる回復のために調整されたプログラムを、管理された環境で提供しています。小児医療や老人医療を含む専門センターは、特定の患者集団に特有のニーズに合わせた急性期リハビリテーションサービスを提供します。専門センターは、集学的かつ年齢別の療法を重視しています。

地域別インサイト

南北アメリカの急性期リハビリテーション市場は、先進的なヘルスケアシステムと慢性疾患の高い発生率により、非常に発展しています。リハビリの技術やインフラへの大規模な投資と在宅医療サービスの増加傾向により、同地域での急性期リハビリテーションサービスの普及が拡大しています。欧州連合（EU）域内の国々は、リハビリテーション・サービスの効率と効果を高めることに注力しています。イノベーション助成金や国境を越えたヘルスケアへの取り組みが、EMEA地域全体のケアの進歩を促進しています。中東では医療インフラの整備が急速に進んでおり、特にUAEやサウジアラビアなどの裕福な国々では、専門的なリハビリテーションセンターに対するニーズが高まっています。アフリカでは、資源の制約から急性期リハビリテーションのサービスはより限定的です。アジア太平洋の急性期リハビリテーション市場は、政府のイニシアティブと高齢者人口の増加に後押しされ、急速に拡大しています。支援技術やロボット工学の革新はアジアの先進経済諸国で顕著であり、洗練されたリハビリ機器の開発に継続的な投資が行われています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、急性期リハビリテーション市場の評価において極めて重要です。事業戦略や製品満足度に関する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、急性期リハビリテーション市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.急性期リハビリテーション市場の市場規模および予測は？

2.急性期リハビリテーション市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.急性期リハビリテーション市場の技術動向と規制枠組みは？

4.急性期リハビリテーション市場における主要ベンダーの市場シェアは？

5.急性期リハビリテーション市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患に苦しむ患者の増加
    • 外傷の発生率上昇
  • 抑制要因
    • リハビリセンターの高額な費用
  • 機会
    • 治療の質を向上させる技術の進歩
    • 病院におけるリハビリテーション施設への新たな投資と統合
  • 課題
    • 患者数に比べてリハビリセンターが不足
• 市場セグメンテーション分析
  • フェーズタイプ：急性期の治療に急性期リハビリテーションの必要性が高まっている
  • デバイス製品：急性期リハビリテーションセンターでのローワーの使用の増加
  • 疾患タイプ：高血圧の問題を克服するための急性期リハビリテーションに対する消費者の好み
  • エンドユーザータイプ：リハビリセンターにおける高度な急性期リハビリテーションソリューションの可用性
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 急性期リハビリテーション市場フェーズタイプ別

• フェーズI-急性期
• フェーズ II-亜急性期
• フェーズIII-集中外来治療
• フェーズIV-独立した継続的なコンディショニング

第7章 急性期リハビリテーション市場デバイス別製品

• 血圧モニタ
• 心拍数モニター
• 漕ぎ手
• 座位・直立型エリプティカルトレーナー
• 安定化ボール
• エアロバイク
• トレッドミル

第8章 急性期リハビリテーション市場：疾患タイプ別

• 異常な心拍リズム
• 狭心症
• 心房細動
• コレステロール管理
• 冠動脈バイパス手術
• 冠動脈疾患または末梢動脈疾患
• 糖尿病
• 心不全または移植
• 高血圧
• 肺高血圧症

第9章 急性期リハビリテーション市場エンドユーザータイプ別

• ホームケア
• 病院・クリニック
• リハビリテーションセンター
• 専門センター

第10章 南北アメリカの急性期リハビリテーション市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の急性期リハビリテーション市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの急性期リハビリテーション市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • フロリダに50床の入院リハビリテーション病院、エンコンパスヘルス・リハビリテーション病院オブクレルモンがオープン
  • ライフポイント・ヘルス、エベレスト・リハビリテーション病院から入院リハビリ施設4施設を買収
  • サイオンヘルス、フロリダ州オーランドの新専門病院建設のためアップショット・キャピタル・アドバイザーズとリース契約を締結

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. ACUTE REHABILITATION MARKET RESEARCH PROCESS
• FIGURE 2. ACUTE REHABILITATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. ACUTE REHABILITATION MARKET DYNAMICS
• FIGURE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. ACUTE REHABILITATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. ACUTE REHABILITATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ACUTE REHABILITATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL ACUTE REHABILITATION MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I- ACUTE PHASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE I- ACUTE PHASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II- SUBACUTE PHASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE II- SUBACUTE PHASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III- INTENSIVE OUTPATIENT THERAPY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE III- INTENSIVE OUTPATIENT THERAPY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV- INDEPENDENT ONGOING CONDITIONING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PHASE IV- INDEPENDENT ONGOING CONDITIONING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BLOOD PRESSURE MONITOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY BLOOD PRESSURE MONITOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART RATE MONITOR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART RATE MONITOR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROWER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ROWER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SEATED & UPRIGHT ELLIPTICAL TRAINER, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SEATED & UPRIGHT ELLIPTICAL TRAINER, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STABILIZATION BALL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STABILIZATION BALL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STATIONARY BICYCLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY STATIONARY BICYCLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TREADMILL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY TREADMILL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ABNORMAL HEART RHYTHMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ANGINA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CHOLESTEROL MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY ARTERY BYPASS SURGERY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY CORONARY OR PERIPHERAL ARTERY DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HEART FAILURE OR TRANSPLANT, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HIGH BLOOD PRESSURE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOME CARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL ACUTE REHABILITATION MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 66. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 75. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 76. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 77. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 78. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 81. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 82. ARGENTINA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 83. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 84. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 85. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 86. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 87. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 88. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 91. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 92. CANADA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 93. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 94. CANADA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 95. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 96. CANADA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 97. CANADA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 98. CANADA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 103. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 104. MEXICO ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 105. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 106. MEXICO ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 115. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 116. UNITED STATES ACUTE REHABILITATION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 131. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 132. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 133. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 134. AUSTRALIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 135. CHINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 136. CHINA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 137. CHINA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 138. CHINA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 139. CHINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 140. CHINA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 141. CHINA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 142. CHINA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 143. INDIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 144. INDIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 145. INDIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 146. INDIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 147. INDIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 148. INDIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 149. INDIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 150. INDIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 151. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 152. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 155. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 156. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 159. JAPAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 160. JAPAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 161. JAPAN ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 162. JAPAN ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 165. JAPAN ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 166. JAPAN ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 167. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 168. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 169. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 170. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 171. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 172. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 175. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 176. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 177. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 178. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 179. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 180. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 181. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 182. PHILIPPINES ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 183. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 184. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 185. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 186. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 187. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 188. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 189. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 190. SINGAPORE ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 191. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 192. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 193. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 196. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 197. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 198. SOUTH KOREA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 199. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 200. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 201. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 202. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 203. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 204. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 205. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 206. TAIWAN ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 207. THAILAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 208. THAILAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 209. THAILAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 210. THAILAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 211. THAILAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 212. THAILAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 213. THAILAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 214. THAILAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 215. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 216. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 217. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 218. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 219. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 220. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 221. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 222. VIETNAM ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA ACUTE REHABILITATION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 233. DENMARK ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 234. DENMARK ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 235. DENMARK ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 236. DENMARK ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 237. DENMARK ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 238. DENMARK ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 239. DENMARK ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 240. DENMARK ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 241. EGYPT ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 242. EGYPT ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 243. EGYPT ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. EGYPT ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. EGYPT ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 246. EGYPT ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 247. EGYPT ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 248. EGYPT ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 249. FINLAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 250. FINLAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 251. FINLAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 252. FINLAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 253. FINLAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 254. FINLAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 255. FINLAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 256. FINLAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 257. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 258. FRANCE ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 259. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 260. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 261. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 262. FRANCE ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 263. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 264. FRANCE ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 265. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 266. GERMANY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 267. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 268. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 269. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 270. GERMANY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 271. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 272. GERMANY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 273. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 274. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 275. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 276. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 277. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 278. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 279. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 280. ISRAEL ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 281. ITALY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 282. ITALY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 283. ITALY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 284. ITALY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 285. ITALY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 286. ITALY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 287. ITALY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 288. ITALY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 289. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 290. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 291. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 292. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 293. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 294. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 295. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 296. NETHERLANDS ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 297. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 298. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 299. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 300. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 301. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 302. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 303. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 304. NIGERIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 305. NORWAY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 306. NORWAY ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 307. NORWAY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 308. NORWAY ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 309. NORWAY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 310. NORWAY ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 311. NORWAY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 312. NORWAY ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 313. POLAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 314. POLAND ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 315. POLAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 316. POLAND ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 317. POLAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 318. POLAND ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 319. POLAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 320. POLAND ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 321. QATAR ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 322. QATAR ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 323. QATAR ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 324. QATAR ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 325. QATAR ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 326. QATAR ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 327. QATAR ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 328. QATAR ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 329. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2018-2023 (USD MILLION)
• TABLE 330. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY PHASE TYPE, 2024-2030 (USD MILLION)
• TABLE 331. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2018-2023 (USD MILLION)
• TABLE 332. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY DEVICES PRODUCT, 2024-2030 (USD MILLION)
• TABLE 333. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2018-2023 (USD MILLION)
• TABLE 334. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY DISEASE TYPE, 2024-2030 (USD MILLION)
• TABLE 335. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2018-2023 (USD MILLION)
• TABLE 336. RUSSIA ACUTE REHABILITATION MARKET SIZE, BY END-USER TYPE, 2024-2030 (USD MILLION)
• TABLE 337. SAUDI ARABIA ACU

[199 Pages Report] The Acute Rehabilitation Market size was estimated at USD 54.67 billion in 2023 and expected to reach USD 59.17 billion in 2024, at a CAGR 8.45% to reach USD 96.48 billion by 2030.

Acute rehabilitation is a specialized form of medical care designed for patients who have experienced severe injuries, surgeries, or acute illnesses that require intensive physical therapy, occupational therapy, and speech-language pathology. Acute rehabilitation aims to help patients regain their functional capabilities and independence to the highest level possible following a significant health event. Aging populations and an elevation in the incidence of chronic diseases drive the need for acute rehabilitation services. In addition, government and insurance policies and funding for rehabilitation services greatly influence the penetration and usage of acute rehabilitation services. However, the high costs of specialized treatments and the shortage of trained professionals in the rehabilitation sector limit the adoption of acute rehabilitation solutions worldwide. Nevertheless, innovative therapies such as robotic-assisted rehabilitation and virtual reality can enhance treatment outcomes and efficiency. Incorporating telerehabilitation services, driven by advancements in telehealth, presents opportunities for reaching more patients, especially in remote areas. Additionally, integrating artificial intelligence in treatment regimens can optimize personalized care plans, potentially improving patient outcomes associated with acute rehabilitation in the coming years.

Phase Type: Increasing need for acute rehabilitation to treat acute phase

In Phase I, patients require close medical supervision and support following a severe injury or onset of illness. Rehabilitation begins very early, often within a hospital setting, where the main goal is to stabilize the patient's medical condition and begin early mobilization to avoid issues associated with prolonged bed rest. Patients who benefit most from Phase I are those who are medically unstable and need immediate, intensive medical care and rehabilitation services. Once patients are medically stable and can tolerate a more extended rehabilitation session, they transition to Phase II. Phase II is best suited for those who have progressed from the acute phase but still require substantial nursing and rehabilitation support that cannot be provided on an outpatient basis. During Phase III, patients continue their rehabilitation through intensive outpatient therapy. Ideal candidates for Phase III are individuals who have progressed sufficiently to perform basic daily activities with minimal assistance but still benefit from focused rehabilitation sessions. Phase IV represents the final stage in the rehabilitation process, where patients commence an independent and ongoing conditioning program. This phase serves those who have regained significant independence and can manage their conditioning programs with occasional supervision from healthcare professionals.

Devices Product: Increasing usage of rowers in acute rehabilitation centers

Blood pressure monitors are essential devices for monitoring a patient's blood pressure levels, crucial in managing heart conditions and assessing overall health. Blood pressure monitors are preferred based on their accuracy and data recording capabilities. Heart rate monitors track the heart's rhythm and rate, providing data to optimize rehabilitation sessions and monitor cardiac health progress. Rowers are preferred in acute rehab for their low-impact, full-body workout capabilities, improving cardiovascular fitness and muscle strength. The rowers' choice depends on their durability, resistance levels, and ergonomic design. Seated and upright elliptical trainers are diverse in their application, offering joint-friendly cardiovascular workouts. Stabilization balls are chosen to improve balance, coordination, and core strength. Preferences often relate to the quality of the material, size variety, and the ball's load-bearing capacity. Stationary bicycles are selected for rehabilitation due to their effectiveness in aerobic conditioning and lower body strengthening without high impact on joints. Treadmills remain a staple for cardiovascular and endurance exercises in acute rehabilitation. The demand is typically for treadmills with variable inclines, speeds, and cushioning to accommodate different recovery phases.

Disease Type: Consumer preference for acute rehabilitation to overcome high blood pressure issues

Abnormal heart rhythms, or arrhythmias, are conditions where the heart beats irregularly. Rehabilitation for these patients includes medication adherence, lifestyle adjustments, and possibly the implementation of pacemakers or defibrillators. Angina caused by decreased blood flow to the heart and can be indicative of coronary artery disease. Rehabilitation often involves exercise programs, stress reduction, and dietary changes to manage symptoms and improve cardiovascular health. Atrial fibrillation (AFib) is a common type of severe heart rhythm abnormality, especially among the elderly. Anticoagulants to prevent stroke are a primary treatment, alongside interventions to control heart rate and rhythm. Effective cholesterol management is crucial in the rehabilitation process for patients with cardiovascular diseases to prevent further complications. Coronary artery bypass surgery is a significant surgical intervention for severe coronary artery disease. Post-operative rehabilitation includes physical therapy and lifestyle modifications. Treatment for coronary or peripheral artery disease (PAD) includes lifestyle modification, medication, and potentially surgical intervention. Diabetes management involves blood sugar monitoring, insulin therapy, dietary regulation, and education. Major manufacturers offer continuous glucose monitors and insulin pumps to aid in patient management. Patients with heart failure or post-heart transplant have specialized rehabilitation needs to manage symptoms, improve functional capacity, and reduce hospital readmission rates. Proper management of high blood pressure is vital to prevent complications such as stroke and heart disease. Pulmonary hypertension requires complex management involving medications to lower blood pressure and surgical procedures.

End-User Type: Availability of advanced acute rehabilitation solutions in rehabilitation centers

Home care in acute rehabilitation constitutes the services and interventions designed to be administered in the patient's residence. Home care caters to individuals who may either be transitioning from hospital care or require ongoing rehabilitation but with a lesser degree of medical complexity. Hospitals and clinics are pivotal in delivering inpatient and outpatient rehabilitation services. These institutions manage a broad spectrum of rehabilitation needs ranging from mild to severe. They typically have structured acute rehabilitation programs equipped with multispecialty teams to provide intensive care. Rehabilitation centers are specialized facilities dedicated to recovering patients with significant functional deficits. These centers provide a controlled environment with programs tailored for extensive recovery, including physical, occupational, and speech therapies. Specialty centers, including those focused on pediatric and geriatric care, provide acute rehabilitation services catered to their specific patient populations' unique needs. Specialty centers emphasize multidisciplinary and age-specific therapies.

Regional Insights

The acute rehabilitation market in the Americas is highly developing due to its advanced healthcare system and high incidence of chronic diseases. The significant investments in rehabilitative technology and infrastructure, with a growing trend towards home health services, have expanded the penetration of acute rehabilitation services in the region. Countries within the European Union are focusing on enhancing the efficiency and effectiveness of rehabilitation services. Innovation grants and cross-border healthcare initiatives are fostering advancements in care across the EMEA region. The Middle East is rapidly developing its healthcare infrastructure, with a growing need for specialized rehabilitation centers, especially in wealthier countries, including the UAE and Saudi Arabia. In Africa, acute rehabilitation services are more limited due to resource constraints. Asia-Pacific's acute rehabilitation market is expanding rapidly, propelled by governmental initiatives and a growing elderly population. Innovations in assistive technologies and robotics are prominent in the developed economies of Asia, with consistent investment in developing sophisticated rehabilitation equipment.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Acute Rehabilitation Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Acute Rehabilitation Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Acute Rehabilitation Market, highlighting leading vendors and their innovative profiles. These include Acadia Healthcare Company, Inc., Amedisys, Inc., Athena Health Care Systems, Aurora Behavioral Health System, Cambridge Medical and Rehabilitation Center, CareOne LLC, Covenant Care, Encompass Health Corporation, Five Star Senior Living, Genesis HealthCare, Haven Behavioral Healthcare Inc., Kindred Healthcare, LLC, LHC Group Inc., National Healthcare Corporation, Nexion Health, Inc., Promises Behavioral Health, LLC, Select Medical Holdings Corporation, Springstone, Inc., St. Ann's Community, Tenet Healthcare Corporation, The Alden Network, The Ensign Group, Inc., Universal Health Services Inc., and Vitas Healthcare.

Market Segmentation & Coverage

This research report categorizes the Acute Rehabilitation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Phase Type
  • Phase I- Acute Phase
  • Phase II- Subacute Phase
  • Phase III- Intensive Outpatient Therapy
  • Phase IV- Independent Ongoing Conditioning

• Devices Product
  • Blood Pressure Monitor
  • Heart Rate Monitor
  • Rower
  • Seated & Upright Elliptical Trainer
  • Stabilization Ball
  • Stationary Bicycle
  • Treadmill

• Disease Type
  • Abnormal Heart Rhythms
  • Angina
  • Atrial Fibrillation
  • Cholesterol Management
  • Coronary Artery Bypass Surgery
  • Coronary or Peripheral Artery Disease
  • Diabetes
  • Heart Failure or Transplant
  • High Blood Pressure
  • Pulmonary Hypertension

• End-User Type
  • Home Care
  • Hospitals & Clinics
  • Rehabilitation Centers
  • Specialty Centers

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Acute Rehabilitation Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Acute Rehabilitation Market?

3. What are the technology trends and regulatory frameworks in the Acute Rehabilitation Market?

4. What is the market share of the leading vendors in the Acute Rehabilitation Market?

5. Which modes and strategic moves are suitable for entering the Acute Rehabilitation Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Patients Suffering from Chronic Diseases
    • 5.1.1.2. Rising Incidence of Trauma
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Rehabilitation Center
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements for Improving Quality of Treatment
    • 5.1.3.2. Emerging Investment and Integration of Rehabilitation Facilities in Hospitals
  • 5.1.4. Challenges
    • 5.1.4.1. Insufficient Rehabilitation Centers in Compared to the number of Patients
• 5.2. Market Segmentation Analysis
  • 5.2.1. Phase Type: Increasing need for acute rehabilitation to treat acute phase
  • 5.2.2. Devices Product: Increasing usage of rowers in acute rehabilitation centers
  • 5.2.3. Disease Type: Consumer preference for acute rehabilitation to overcome high blood pressure issues
  • 5.2.4. End-User Type: Availability of advanced acute rehabilitation solutions in rehabilitation centers
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Acute Rehabilitation Market, by Phase Type

• 6.1. Introduction
• 6.2. Phase I- Acute Phase
• 6.3. Phase II- Subacute Phase
• 6.4. Phase III- Intensive Outpatient Therapy
• 6.5. Phase IV- Independent Ongoing Conditioning

7. Acute Rehabilitation Market, by Devices Product

• 7.1. Introduction
• 7.2. Blood Pressure Monitor
• 7.3. Heart Rate Monitor
• 7.4. Rower
• 7.5. Seated & Upright Elliptical Trainer
• 7.6. Stabilization Ball
• 7.7. Stationary Bicycle
• 7.8. Treadmill

8. Acute Rehabilitation Market, by Disease Type

• 8.1. Introduction
• 8.2. Abnormal Heart Rhythms
• 8.3. Angina
• 8.4. Atrial Fibrillation
• 8.5. Cholesterol Management
• 8.6. Coronary Artery Bypass Surgery
• 8.7. Coronary or Peripheral Artery Disease
• 8.8. Diabetes
• 8.9. Heart Failure or Transplant
• 8.10. High Blood Pressure
• 8.11. Pulmonary Hypertension

9. Acute Rehabilitation Market, by End-User Type

• 9.1. Introduction
• 9.2. Home Care
• 9.3. Hospitals & Clinics
• 9.4. Rehabilitation Centers
• 9.5. Specialty Centers

10. Americas Acute Rehabilitation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Acute Rehabilitation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Acute Rehabilitation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Encompass Health Rehabilitation Hospital of Clermont, a 50-bed inpatient rehabilitation hospital, now open in Florida
  • 13.3.2. Lifepoint Health Acquires Four Inpatient Rehabilitation Facilities From Everest Rehabilitation Hospitals
  • 13.3.3. ScionHealth Announces Lease Agreement with Upshot Capital Advisors for a New Specialty Hospital in Orlando, Florida

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio